|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-0.86/-0.66
|
企业价值
94.63M
|
资产负债 |
每股账面净值
0.91
|
现金流量 |
现金流量率
--
|
损益表 |
收益
20.13M
|
每股收益
0.16
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟:2024/05/06 00:26 EDT
同行比较之报价最少15分钟延迟
业务概览
|
|||
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies. |